secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-08-27T21:29:32+00:00
Accession:  0001213900-26-094447
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical appoints Robert Potashnick as Chief Accounting Officer and VP of Finance
--------------------------------------------------------------------------------

- Base salary $315,000/yr; initial target bonus of 15% of salary tied to performance milestones.
- Initial equity award of 250,000 stock options at $0.746/share (Aug 24, 2026 closing price).
- Employment agreement provides 6 months severance for qualifying terminations; 3-year term with auto-renewal.
- Potashnick previously served as Interim CFO on contractor basis; prior CFO at FOXO Technologies and Flutterbee Education Group.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026094447/0001213900-26-094447-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026094447/ea0303543-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-094447

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer